The use of polymerase chain reaction in plasma pools for the concomitant detection of hepatitis C virus and HIV type 1 RNA

Transfusion

Volumn 38, Issue 10, 1998, Pages 908-914

  Yerly, S ^a   Pedrocchi, M ^b   Perrin, L ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Diagnostics Division   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; POLYMERASE CHAIN REACTION; VIRUS DETECTION;

EID: 0031720277     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.381098440854.x     Document Type: Article

References (33)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-90.
2. Kleinman SH, Busch MP. General overview of transfusion-transmitted infections. In: Petz LD, Swisher S, Kleinman SH, et al. eds. Clinical practice of transfusion medicine. 3rd ed. New York: Churchill Livingstone, 1996:809-21.
3. Holland PV. Viral infections and the blood supply (editorial). N Engl J Med 1996;334:1734-5.
4. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of human immunodeficiency virus by screened blood in the United States. N Engl Med 1995;333:1721-5.
5. Nelson KE, Donahue JG, Munoz A, et al. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections. Ann Intern Med 1992;117:554-9.
6. Kitchen AD, Wallis PA, Gorman M. Donor-to-donor and donor-to-patient transmission of hepatitis C virus. Vox Sang 1996;70:112-3.
7. Vrielink H, Zaaijer HL, Reesink HW, et al. Sensitivity and specificity of three third-generation anti-hepatitis C virus ELISAs. Vox Sang 1995;69:14-7.
8. Donahue JG, Nelson KE, Munoz A, et al. Transmission of HIV by transfusion of screened blood (letter). N Engl J Med 1990;323:1709.
9. Ward JW, Holmberg SD, Allen JR, et al. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. N Engl J Med 1988;318:473-8.
10. Lim SG, Lee CA, Charman H, et al. Hepatitis C antibody assay in a longitudinal study of haemophiliacs. Br J Haematol 1991;78:398-402.
11. Van der Poel CL, Bresters D, Reesink HW, et al. Early anti-hepatitis C virus response with second-generation C200/ C22 ELISA. Vox Sang 1992;62:208-12.
12. Farci P, Alter HJ, Wong D, et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991;325:98-104.
13. Busch MP, Lee LLL, Satten GA, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995;35:91-7.
14. Shindo M, Di Bisceglie AM, Biswas R, et al. Hepatitis C virus replication during acute infection in the chimpanzee. J Infect Dis 1992;166:424-7.
15. De Saussure P, Yerly S, Tullen E, Perrin LH. Human immunodeficiency virus type 1 nucleic acids detected before p24 antigenemia in a blood donor. Transfusion 1993;33:164-7.
16. Alter HJ. To C or not to C: these are the questions. Blood 1995;85:1681-95.
17. AuBuchon JP, Birkmeyer JD, Busch MP. Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion 1997;37:45-51.
18. Schockmel G, Yerly S, Perrin L. Detection of low HIV-1 RNA levels in plasma. J Acquir Immune Defic Syndr Hum Retroviral 1997;14:179-83.
19. Busch MP. HIV and blood transfusion: focus on seroconversion. Vox Sang 1994;67(Suppl 3):13-8.
20. Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 1997;102:117-24.
21. Bukh J, Purcell RH, Miller RH. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci U S A 1992;89:187-91.
22. Young K, Resnick R, Myers T. Detection of hepatitis C virus RNA by combined reverse transcriptase-polymerase chain reaction assay. J Clin Microbiol 1993;31:882-6.
23. Myers G, Korber B, Wain-Hobson S, et al. Human retroviruses and AIDS: a compilation and analysis of nucleic and amino acid sequences. Los Alamos, NM: Theoretical Biology and Biophysics, Los Alamos National Laboratory, 1995.
24. Diaz RS, Sabino EC, Mayer A, et al. Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group. J Virol 1995;69:3273-81.
25. Michael N, Robb M, Birx D, et al. Performance of the Amplicor HIV-1 Monitor test and a modified HIV-1 Monitor test on HIV-1 subtypes A to F (abstract). Presented at the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997:116.
26. Widell A, Elmud H, Persson MH, Jonsson M. Transmission of hepatitis C via both erythrocyte and platelet transfusions from a single donor in serological window-phase of hepatitis C. Vox Sang 1996;71:55-7.
27. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A,non-B Hepatitis Study Team. N Engl J Med 1992;327:1899-905.
28. Kao JH, Lai MY, Hwang YT, et al. Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay. A clinicopathologic study and demonstration of the usefulness of a third-generation assay. Dig Dis Sci 1996;41:161-5.
29. Sugitani M, Inchauspé G, Shindo M, Prince AM. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet 1992;339:1018-9.
30. Bukh J, Wantzin P, Krogsgaard K, et al. High prevalence of HCV RNA in dialysis patients: failure of commercial available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 1993;168:1343-8.
31. Kao JH, Chen PJ, Yang PM, et al. Absence of extensive genetic heterogeneity of hepatitis C virus in antibody-negative chronic hepatitis C. J Med Virol 1996;49:87-90.
32. Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
33. Longo MC, Berninger MS, Hartley JL. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 1990;93:125-8.